Aero Financial, Inc.
Aero Financial Acquires Controlling Interest in Entelechis Corporation
Published in Healthcare Mergers, Acquisitions and Ventures Week, November 7th, 2009
Aero Financial was a founding investor in Entelechis and has been an ongoing consultant to the company for over four years. Under the terms of the agreement, Aero Financial has agreed to assume certain liabilities of the company for the control equity position. Don Tolman will remain the company CEO, and will continue to create and market innovative health, educational and nutritional products and services that are sold through the company's website as well as national and international seminars.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Abbott
Abbott Completes Visiogen Acquisition - AnaSpec, Inc.
Eurogentec Announces Agreement to Acquire AnaSpec, Inc. - Biogen Idec Inc.
Biogen Idec Extends Offer to Acquire Facet Biotech Corporation for $14.50 Per Share in Cash - Biomet, Inc.
Biomet Announces Acquisition of the Assets of Cartilage Repair Company Cartilix - Bioscience
OriGene Technologies Acquires Marligen Biosciences - Continucare Corporation
Continucare Expands Sleep Diagnostic Division with the Acquisition of Two Additional Centers - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
